Editorial note: this analysis reflects publicly available research and sector frameworks, not personal trading experience.
The Common Belief
Fifty-seven percent.
That is the number that anchors nearly every recession-investing article ever written. According to historical index data from S&P Dow Jones Indices, the S&P 500 fell roughly 57% peak-to-trough during the 2007–2009 recession — from a high of 1,565 on October 9, 2007 to a low of 677 on March 9, 2009. Consumer staples and healthcare fell too, but they fell markedly less than financials and consumer discretionary. From that single, brutal episode, an entire investing folk wisdom was built: when a downturn comes, rotate into things people cannot stop buying — food, medicine, electricity.
According to AI Fallback, whose reporting forms the factual basis for this piece, the defensive framework remains the dominant answer to the question of where to hide in a recession. The logic is genuinely sound. Demand for staples, healthcare and utilities is inelastic (meaning people buy roughly the same amount whether the economy is booming or shrinking), so earnings hold up when cyclical earnings collapse. Utilities have historically carried dividend yields in the 3–4% range, which matters enormously in a period when capital appreciation is scarce — if the price of a stock goes nowhere for two years, a 3.5% yield is the entire return.
Our thesis: the defensive-sector playbook is correct about which stocks fall least, and that is a different question from which stocks make you the most money over a full recession-and-recovery cycle. Confusing the two is the most expensive mistake in recession investing.
Where the Playbook Quietly Breaks Down
Here is the non-obvious part that most sector-rotation coverage skips: the sources that investors treat as interchangeable authorities actually disagree with each other, and the disagreement is the most useful thing in the entire research file.
Fidelity's business-cycle framework is explicitly structural. It maps the economy into phases and assigns sector leadership to each: late-cycle and recession phases favor health care, consumer staples and utilities, while early-recovery phases favor cyclicals. It is a clean, rules-based system. Morningstar approaches the same downturn from an entirely different direction, emphasizing valuation and economic moat quality over sector labels, and arguing that some cyclicals become genuinely attractive precisely because they have been priced for disaster. Investopedia sits in between, cataloguing specific recession-resistant industries — discount retailers, healthcare, consumer staples — with named company examples.
Strip away the branding and the divergence is philosophical: Fidelity is answering a timing question, Morningstar is answering a price question. A framework investor sells industrials because the calendar says contraction. A valuation investor buys the same industrials because they now trade at a discount to what the business is worth across a full cycle. Both can be right, and they will hold opposite positions at the same moment.
The reconciliation matters more than either view alone. If you rotate defensively at the top and rotate back into cyclicals at the bottom, you capture both. But that requires two correct timing calls, not one — and the second call is the hard one, because equity markets have historically begun rebounding before a recession is officially declared over. This is the mechanical reason advisors repeat that time in the market beats timing the market. It is not a platitude about patience. It is a statement about the asymmetric cost of being out of stocks during the specific weeks when the recovery starts.
Running the Numbers on What Defense Actually Buys You
Consider what the 2008 figure implies in dollars, because the percentage abstracts away how violent the arithmetic is.
A $100,000 broad-market position that fell 57% became roughly $43,000. To get back to $100,000, that $43,000 must gain about 133% — because a 57% loss requires a 133% gain to break even, not a 57% gain. That asymmetry is the entire case for defense. The research does not give sector-specific drawdown percentages for staples and healthcare in 2008, only that they "declined significantly less" than cyclicals. But the shape of the math is unforgiving enough that even a modest reduction in drawdown compounds into a materially shorter recovery period.
Chart: Recovery math. The green bar is the actual 2007–2009 S&P 500 peak-to-trough decline of approximately 57% per S&P Dow Jones Indices historical index data; the required break-even gain is calculated from that figure. Smaller drawdowns compound into disproportionately faster recoveries.
Now flip it. Yield is the other half of the defensive case and it is the half that gets underweighted. On a $100,000 utilities position at a 3.5% historical yield, that is $3,500 a year in cash regardless of what the share price does. Over a two-year contraction where prices go sideways, that is $7,000 of realized return — money that arrives whether or not the timing call was right. Dividend Aristocrats, the S&P 500 companies with 25 or more consecutive years of dividend increases, concentrate in staples and industrials and have historically shown lower drawdowns in bear markets. That combination — smaller hole, paid while you wait — is the actual mechanism, not vague "safety."
Healthcare deserves separate treatment because its defensiveness is structural rather than behavioral. U.S. healthcare spending runs roughly 17–18% of GDP, and that share is supported by demographics rather than sentiment. A household under financial strain cancels a vacation before it cancels a prescription. That is a different kind of durability than a consumer staples company enjoys, where trade-down risk is real even if total volume holds.
Photo by Franki Chamaki on Unsplash
The Bear Case Deserves Better Than a Paragraph
The strongest argument against the entire defensive framework is not that defensives underperform — it is that the framework was calibrated on a recession that may not repeat in form.
Start with 2020. The COVID recession punished travel and energy severely while boosting technology and e-commerce. Technology, the textbook cyclical, behaved defensively because it was the delivery mechanism for how a locked-down economy kept functioning. Any investor who mechanically dumped tech in February 2020 because the framework said "cyclicals underperform in recessions" made a costly, framework-obedient error. The research is explicit that the best-performing sector varies by recession, and 2020 is the proof.
Second, the AI variable genuinely complicates the taxonomy. If AI-driven productivity gains let selected technology companies cut costs and defend margins through a slowdown, the clean cyclical-versus-defensive line blurs further. This is a hypothesis, not a demonstrated outcome — no recession has yet tested it — and a careful skeptic should note that enterprise software spending is still a budget line that CFOs can cut. But the direction of the argument is credible enough that treating "tech" as a single cyclical bucket is now analytically lazy.
Third, and most concretely: rate policy cuts across sector labels. Government bonds, particularly U.S. Treasuries, often rally as the Federal Reserve cuts rates to stimulate a weakening economy, and gold retains its traditional safe-haven role. But those same rate moves are the dominant driver for utilities, real estate and financials. A utility is not simply a defensive stock; it is a rate-sensitive, capital-intensive, dividend-paying instrument whose valuation responds to the discount rate as much as to consumer behavior. The persistent 2024–2025 debate over whether the U.S. would achieve a soft landing (disinflation without a recession) versus a genuine downturn shaped these rotation strategies for two years — and getting the rate path wrong could scramble the defensive trade even if the recession call was right.
Fourth: crowding. When a framework becomes universally known, its recommended positions get bid up in advance. Buying "safety" after everyone has agreed it is safe means paying a premium for lower expected returns. Morningstar's valuation objection is exactly this point in professional language.
Watchlist: What to Actually Track
Rather than a set of holdings, the more useful output is a set of observable metrics that would confirm or falsify the defensive thesis in real time.
The defensive thesis is a relative claim. Staples and healthcare can fall in a bear market and still be doing their job. Comparing staples-sector returns against the S&P 500 over rolling periods is the honest test; comparing them against zero is not. Companies like Procter & Gamble, Coca-Cola and Walmart are cited across sources as the archetypes of non-discretionary revenue, and their earnings resilience across cycles is the observable variable — not their share price in any given month.
Federal Reserve policy shifts remain the dominant driver for utilities, real estate and financials heading into any slowdown. An investor holding utilities primarily for a 3–4% yield is implicitly taking a duration position. Knowing that is different from discovering it.
Fidelity's cycle framework and Morningstar's valuation discipline lead to different portfolios at the same moment. The failure mode is drifting between them — rotating defensively at the bottom because it feels safe, then chasing cyclicals at the top because they are working. Writing down the rule before the drawdown is the part that is genuinely hard. This same tension between a rigid rulebook and situational judgment shows up outside investing too — the verification checklist approach documented on Automation makes a similar case for deciding your method before the headline arrives.
Bottom Line
As of August 10, 2026, the research consensus is that defensive sectors — consumer staples, healthcare and utilities — have historically outperformed the broad market during contractions, and that cyclicals including consumer discretionary, industrials, materials, financials and technology have typically lagged as households and companies cut discretionary and capital spending. That is well established and worth researching further.
Our analysis: the more consequential finding is not which sectors defend, but that the defensive trade is a two-decision strategy sold as a one-decision strategy. Getting into defensives is easy and comfortable. Getting back out, into beaten-down cyclicals, at the exact moment the news is worst, is where the actual return lives — and it is where most investors, on balance, fail. Data suggests the investors who fully exit equities to avoid a downturn frequently miss the sharp rebound that begins before the recession is formally over, which is why the sector question and the staying-invested question are not the same question at all.
Frequently Asked Questions
Which sectors do best during a recession, historically?
Consumer staples, healthcare and utilities have historically outperformed the broader market during recessions, because demand for food, medicine and electricity is inelastic and continues regardless of the economic cycle. Fidelity's business-cycle framework identifies these same three as late-cycle and recession outperformers, with cyclicals favored in early-recovery phases. Note that "outperform" means falling less than the market, not necessarily rising.
Do utilities and consumer staples really outperform in a recession?
The historical record supports it on a relative basis. Utilities are valued in downturns for high, stable dividend yields — historically in the roughly 3–4% range — which supply income return when capital appreciation is scarce. Consumer staples companies such as Procter & Gamble, Coca-Cola and Walmart derive revenue from non-discretionary purchases, giving earnings resilience across cycles. The important caveat is that utilities are also rate-sensitive, so Federal Reserve policy can affect them independently of consumer behavior.
Should I move to cash before a recession?
Many advisors caution against it, on the grounds that fully exiting equities risks missing the sharp rebounds that typically begin before a recession is officially declared over. The recovery math is the reason this is costly: recovering from a 57% decline like 2007–2009 requires a subsequent gain of roughly 133% just to break even, and missing the earliest and steepest part of that recovery is difficult to make up. This is educational context, not a recommendation — individual circumstances differ substantially.
Is it good to invest during a recession, or should you wait?
Sources diverge here, which is itself informative. Framework-based sources like Fidelity favor rotating into defensives during the contraction phase. Valuation-oriented sources like Morningstar argue that buying beaten-down quality cyclicals at depressed prices can outperform on the recovery, prioritizing moat quality and valuation over sector labels. The difference is a timing philosophy versus a price philosophy, and investors are watching both.
Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. No independent product or investment testing was conducted; this is editorial commentary based on publicly reported research and sector frameworks. Always do your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of August 10, 2026.